Follow
Oleg Levada
Oleg Levada
Other namesЛевада О.А., Левада ОА, Oleg A. Levada
Zaporizhzhia State Medical and Pharmaceutical University
Verified email at zsmu.edu.ua
Title
Cited by
Cited by
Year
Poststroke depression biomarkers: a narrative review
OA Levada, AS Troyan
Frontiers in Neurology 9, 362121, 2018
742018
Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder
OA Levada, AS Troyan
Annals of general psychiatry 16 (1), 38, 2017
502017
Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram
OA Levada, AS Troyan
Journal of affective disorders 250, 114-122, 2019
432019
Белок S100В: нейробиология, значение при неврологической и психиатрической патологии
АВ Траилин, ОА Левада
Международный неврологический журнал, 166-175, 2009
402009
Plasma brain-derived neurotrophic factor as a biomarker for the main types of mild neurocognitive disorders and treatment efficacy: a preliminary study
OA Levada, NV Cherednichenko, AV Trailin, AS Troyan
Disease markers 2016, 2016
342016
Brain-derived neurotrophic factor (BDNF): neurobiology and marker value in neuropsychiatry
OA Levada, NV Cherednichenko
Likars' ka sprava, 15-25, 2015
282015
Post-stroke depression
OA Levada, EI Slivko
Zhurnal Nevrologii I Psikhiatrii Imeni SS Korsakova, 73-79, 2006
222006
The diagnostic value of the combination of serum brain-derived neurotrophic factor and insulin-like growth factor-1 for major depressive disorder diagnosis and treatment efficacy
AS Troyan, OA Levada
Frontiers in Psychiatry 11, 514735, 2020
182020
Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label …
OA Levada, AS Troyan, IY Pinchuk
BMC psychiatry 20, 1-10, 2020
152020
Major depressive disorder and accelerated aging from a peripheral IGF-1 overexpression perspective
OA Levada, AS Troyan
Medical Hypotheses 138, 109610, 2020
122020
P300 potential parameters at the stages of formation of the subcortical vascular dementia in elderly
OA Levada, AV Trailin, AL Kvitka, OV Stolbinskaia
Likars' ka Sprava, 60-66, 2014
112014
Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness
OA Levada, AV Trailin
ЛІКАРСЬКА СПРАВА ВРАЧЕБНОЕ ДЕЛО, 59, 2012
102012
Актуальні питання геронтопсихіатрії
ОАЛ ІЯ Пінчук, ВВ Чайковська, ЛА Стадник
Тернопіль, 431, 2010
9*2010
Генетика и эпигенетика шизофрении // Нейро news. – 2012. – Т.6, No41.
ЛОА Траилин А.В.
Нейро news 6 (41), 18-28, 2012
8*2012
neuropsychiatric symptoms in Patients with the Main etiological Types of Mild neurocognitive Disorders: a hospital-Based case–control study
OA Levada, NV Cherednichenko, AS Troyan
Frontiers in Psychiatry 8, 251105, 2017
62017
Нейробиология депрессии: от анатомо-функциональных до молекулярных механизмов
ОА Левада
НевроNews 67 (3), 2015
62015
Etiology, clinical variants, diagnosis and treatment tactic of cerebellar infarction
OA Levada
Likars' ka Sprava, 3-6, 2003
62003
Судинна деменція: етіопатогенез, діагностика, сучасні стратегії лікування. Метод. рекомендації
ІЯП ОА Левада
МОЗ України, 25, 2009
52009
Serum serotonin level in patients with depression and panic attacks
OA Levada, NV Cherednichenko, IR Rybak
Likars' ka Sprava, 36-38, 2006
52006
Нейропсихологія болю
ОА Левада
НевроNews 35 (8), 2011
42011
The system can't perform the operation now. Try again later.
Articles 1–20